PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

The Alzheimer's Association recommends against use outside of a research or clinical setting. Read Part 1 of this series: For Your Patients: What Is Alzheimer's Disease?

A single, freely available, noninvasive brain scan done in just a few minutes during midlife can predict what chronic ...

Familial Alzheimer's disease is a rare, inherited form of Alzheimer's, caused by genetic mutations passed through families.

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

Two new drugs for Alzheimer’s have been rejected for use on the NHS. They slow progression of the disease, but they can have serious side-effects.

New scans help Sarasota Memorial doctors identify markers for Alzheimer's disease While the tools for DaTscans and PET scans are not new, some of the applications and upgrades over the past year ...

A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to ...

A colored transmission electron micrograph of the nerve cell of the brain of a patient with Alzheimer’s disease showing aggregates of the protein tau in green. The study used a blood test that ...

A rapidly growing body of research is showing that most dementia cases are preventable, says Jacob Teitelbaum, M.D. Read on for his 7 key strategies that may help.

Alzheimer's disease (AD) is a progressive brain disease that leads to problems with cognitive abilities such as thinking, memory, language, and learning.

In recent years, PET scans have become an important tool to help detect the presence of amyloid plaques – a hallmark of Alzheimer's – and other metabolic changes associated with the disease.